Author

Gina S. Ogilvie

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Human papillomavirus (HPV) and HPV vaccine awareness in Indigenous communities in Northwest Territories, Canada

Objectives Human papillomavirus (HPV) is a common sexually transmitted infection linked to several cancers, including cervical cancer, which ranks fourth in cancer incidence and mortality among women globally. Despite its significance, awareness of HPV and the HPV vaccine remains limited across many populations. This p...

Afsaneh Omidimorad, F. Kolahdooz, Ghazal Kolahdooz et al. · PLoS ONE · 0 citations

Open access Aug 2026

HPV vaccine effectiveness against prevalent HPV by age, years sexually active before vaccination, and HIV status in gay, bisexual, and other men who have sex with men, 2019-2021.

BACKGROUND We compared the prevalence of vaccine-preventable anal human papillomavirus (HPV) types among gay, bisexual, and other men who have sex with men (GBM) living in large cities in Canada from 2019 to 2021 by age and HIV status. METHODS Sexually-active GBM ≥16 years were recruited in Montreal, Toronto, and Van...

Pranamika Khayargoli, Daniel Grace, Joseph Cox et al. · Journal of Infectious Diseas... · 0 citations

Sep 2026

Rationale and design of a clinical trial of a reduced dosing schedule for the nonavalent human papillomavirus vaccine in women living with HIV: The NOVA-HIV study.

Virtually all cases of cervical cancer are caused by human papillomavirus (HPV). Women and people with a cervix living with HIV (women with HIV) are disproportionately impacted by cervical cancer; they experience higher rates of HPV infection and increased susceptibility to persistent HPV infection than women without H...

Emma Karlsen, Jenna Langlois, I. Boucoiran et al. · Contemporary Clinical Trials · 0 citations